Review Article
LncRNA BLACAT1 May Serve as a Prognostic Predictor in Cancer: Evidence from a Meta-Analysis
Table 1
Characteristics of studies included in the meta-analysis.
| Study (year) | Country | Cancer type | Stage | Sample size | BLACAT1 | Specimens | Method | Cut-off | Outcome | HR availability | NOS | High | Low |
| Chen, 2018 | China | Small‐cell lung cancer | I-IV | 106 | 53 | 53 | Tissue | qRT‐PCR | Median | OS | DE | 8 | Droop, 2017 | Germany | Urothelial carcinoma | I-IV | 106 | 53 | 53 | Tissue | qRT‐PCR | Median | OS | DE | 7 | Gao, 2017 | China | Colorectal cancer | I-IV | 96 | 48 | 48 | Tissue | qRT‐PCR | Median | OS | DE | 8 | He, 2013 | China | Urothelial carcinoma | I-IV | 102 | 60 | 42 | Tissue | qRT‐PCR | FC >1.5 | OS | SC | 7 | Hu, 2015 | China | Gastric cancer | I-IV | 85 | 32 | 53 | Tissue | qRT‐PCR | Median | OS | SC | 6 | Liao, 2018 [17] | China | Papillary thyroid cancer | I-IV | 87 | 43 | 44 | Plasma | qRT‐PCR | Median | NR | NR | 7 | Niu, 2018 [18] | China | Esophageal squamous cell carcinoma | I-IV | 50 | 26 | 24 | Tissue | qRT‐PCR | NR | OS | SC | 7 | Su, 2017 | China | Colorectal cancer | I-IV | 48 | 24 | 24 | Tissue | qRT‐PCR | Median | OS | DE | 8 | Wang, 2018 | China | Cervical cancer | I-IV | 133 | 68 | 65 | Tissue | qRT‐PCR | Median | OS | DE | 8 | Ye, 2017 | China | Non-small-cell lung cancer | I-III | 48 | 28 | 20 | Tissue | qRT‐PCR | NR | OS | SC | 7 |
|
|
HR, hazard ratio; NOS, Newcastle-Ottawa Scale; qRT‐PCR, quantitative real time-polymerase chain reaction; OS, overall survival; DE, data extrapolated; FC, fold change; SC, survival curve; NR, not reported.
|